semaglutide and lamotrigine nejm Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has well-established weight-loss benefits. Cagrilintide, a long-acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential Can you take Wegovy if

Electronic databases including PubMed, Embase, and Web of Science were searched from inception until August 2025 using keywords such as GLP-1 receptor agonist, diabetic retinopathy, glaucoma, age-related macular degeneration, ocular disease, and neuroprotection. The search focused on identifying preclinical studies, large-scale retrospective cohort studies, and post-hoc analyses of major clinical trials that evaluated the utility and potential mechanisms of GLP-1RAs in ophthalmic diseases

In female rats, supplementing the diet with spirulina platensis (P41-P55) reversed the POS-induced cognitive impairments measured in AL and the MWM at P60-P70 [153]

It works by suppressing appetite and decreasing the absorption of calories from food

Impact of semaglutide on weight and functional outcomes among obese heart failure patients: a propensity scores matching analysis

This study is expected to enroll ~13,000 patients suffering from obesity

Cross-trial comparisons are inherently limited and do not establish that one approach produces better results than another